AI-powered disease management platform "Jianhai Technology" announces completion of RMB 60 million Series A3 funding round, led by Source Code Capital
Domestic AI-powered disease management platform Hangzhou Jianhai Technology Co., Ltd. (hereinafter referred to as "Jianhai Technology") announced the completion of a RMB 60 million Series A3 funding round, led by Source Code Capital with Sherpa Healthcare Partners participating. TanZhen Capital served as the exclusive financial advisor. Since 2020, Jianhai Technology has raised two funding rounds totaling over RMB 100 million.









